ArticlePloS one2015

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.

Darrell C Bessette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.